Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and efficacy of a dose and dosage regimen of
SBI-087 in seropositive patients with active Rheumatoid Arthritis, who are on a stable dose
of methotrexate.